Evaluating Steris: Insights From 4 Financial Analysts
Portfolio Pulse from Benzinga Insights
In the past three months, four analysts have provided ratings for Steris (NYSE:STE), with the majority being somewhat bullish. The average 12-month price target is $253.75, slightly up from the previous $252.50. Analysts have maintained or raised their ratings, reflecting positive sentiment. Steris has shown solid revenue growth but faces challenges in profitability and return metrics.
August 07, 2024 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have shown a somewhat bullish sentiment towards Steris (NYSE:STE) with an average 12-month price target of $253.75. The company has demonstrated solid revenue growth but faces challenges in profitability and return metrics.
The majority of analysts have a somewhat bullish outlook on Steris, with a slight increase in the average price target. This positive sentiment is likely to have a short-term positive impact on the stock price. However, the company's challenges in profitability and return metrics may temper the overall enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100